Skip to main content
. 2015 Mar 14;5:10. doi: 10.1186/s13550-015-0093-3

Figure 2.

Figure 2

Correlation between pretherapeutic FDG SUVmax and 111 In-ibritumomab tiuxetan SUVmax in all lesions. The solid line is the progression line. Dotted lines represent 95% confidence intervals of the progression line.